NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2

• Femke M. Hormann,
• Alex Q. Hoogkamer,
• H. Berna Beverloo,
• Aurélie Boeree,
• Ilse Dingjan,
• Moniek M. Wattel,
• Ronald W. Stam,
• Gabriele Escherich,
• Rob Pieters,
• Monique L. den Boer,
• Judith M. Boer

Affiliations

Femke M. Hormann

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands;Oncode Institute, Utrecht, the Netherlands

Alex Q. Hoogkamer

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands;Oncode Institute, Utrecht, the Netherlands

H. Berna Beverloo

Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands

Aurélie Boeree

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands;Oncode Institute, Utrecht, the Netherlands

Ilse Dingjan

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands;Oncode Institute, Utrecht, the Netherlands

Moniek M. Wattel

Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands

Ronald W. Stam

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands

Gabriele Escherich

COALL – German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia, Hamburg, Germany

Rob Pieters

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands;DCOG – Dutch Childhood Oncology Group, Utrecht, the Netherlands

Monique L. den Boer

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands;Oncode Institute, Utrecht, the Netherlands;DCOG – Dutch Childhood Oncology Group, Utrecht, the Netherlands;Department of Pediatric Oncology and Hematology, Erasmus Medical Center - Sophia Children’s Hospital, Rotterdam, the Netherlands

Judith M. Boer

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands;Oncode Institute, Utrecht, the Netherlands